Novel uses of combined selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists
Details for Australian Patent Application No. 2002221744 (hide)
Event Publications
2 August 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002221745-4-(biphenylcarbonylamino)piperidine derivatives as MTP inhibitors
2002221743-Absorption agents with a high swelling capacity, with a reduced tendency to cake
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser